These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10543181)

  • 1. [Fibrinopeptide A, fibrinopeptide B beta 15-42].
    Kinoshita T
    Nihon Rinsho; 1999 Sep; 57 Suppl():573-4. PubMed ID: 10543181
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of fibrinopeptide A, fibrinopeptide B beta 15-42, HMW-kininogen and kinin in cases of caesarean section.
    Mutoh S; Teh A; Saitoh M; Abe T; Ohno Y
    Adv Exp Med Biol; 1986; 198 Pt B():35-9. PubMed ID: 3812103
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma fibrinopeptide A and fibrinopeptide B beta 15-42 levels in patients with Behçet's disease].
    Sunakawa M; Arai I; Okinami S
    Nippon Ganka Gakkai Zasshi; 1986 Jun; 90(6):871-4. PubMed ID: 3751789
    [No Abstract]   [Full Text] [Related]  

  • 4. The utility of plasma fibrinopeptide assays.
    Owen J
    Thromb Haemost; 1989 Sep; 62(2):807-10. PubMed ID: 2814929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinopeptide A (FPA), fibrinopeptide B (FPB) and fibrinopeptide Bbeta(15-42) (FPBbeta15-42)].
    Uchiba M; Okajima K
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():615-7. PubMed ID: 15658404
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of fibrinopeptide A, fibrinopeptide B beta 15-42 HMW-kininogen and kinin during normal pregnancy labor and puerperium.
    Mutoh S; Teh A; Saito M; Maki M; Abe T; Ohno Y
    Adv Exp Med Biol; 1986; 198 Pt B():41-4. PubMed ID: 3812106
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical significance of fibrinopeptide A and B beta 15-42 analysis in blood coagulo-fibrinolytic tests].
    Koshihara K; Fuzimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():889-91. PubMed ID: 2622023
    [No Abstract]   [Full Text] [Related]  

  • 8. Hominoid evolution as judged by fibrinopeptide structures.
    Doolittle RF; Wooding GL; Lin Y; Riley M
    J Mol Evol; 1971; 1(1):74-83. PubMed ID: 5006251
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of human fibrinopeptides by high-performance liquid chromatography.
    Kehl M; Lottspeich F; Henschen A
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1661-4. PubMed ID: 7319478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of bovine fibrinopeptides by high performance liquid chromatography.
    Martinelli RA; Scheraga HA
    Anal Biochem; 1979 Jul; 96(1):246-9. PubMed ID: 495988
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoassay of human fibrinopeptides.
    Butler VP; Nossel HL; Canfield RE
    Methods Enzymol; 1982; 84():102-18. PubMed ID: 7048006
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of coagulative and fibrinolytic factors in peripheral and ovarian veins among ovarian cancer patients].
    Ino Y
    Nihon Gan Chiryo Gakkai Shi; 1987 Dec; 22(10):2417-26. PubMed ID: 3130448
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serial changes in FPA and FPB beta 15-42 during surgery with cardiopulmonary bypass].
    Gando S; Tedo I; Tsujinaga H; Kubota M
    Masui; 1988 May; 37(5):541-5. PubMed ID: 3411777
    [No Abstract]   [Full Text] [Related]  

  • 14. Assay of human fibrinopeptides by high-performance liquid chromatography.
    Ebert RF; Bell WR
    Anal Biochem; 1985 Jul; 148(1):70-8. PubMed ID: 4037309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Falsely increased" B beta 15-42 levels in diabetes.
    Marongiu F; Conti M; Mameli G; Sorano GG; Cirillo R; Balestrieri A
    Diabetes Care; 1990 Nov; 13(11):1129-30. PubMed ID: 2082993
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulation-fibrinolysis system on pregnant toxicosis].
    Yoshida A; Morozumi K; Shinmura I; Oikawa T; Gotoh I; Fujimami T; Yagami Y
    Nihon Jinzo Gakkai Shi; 1986 Oct; 28(10):1345-52. PubMed ID: 3820811
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct measurement of a second fibrinogen alpha chain in lamprey blood plasma.
    Doolittle RF; Riley M; Pan Y
    Thromb Res; 1992 Dec; 68(6):489-93. PubMed ID: 1341060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Coagulation-fibrinolysis abnormalities in acute stage of subarachnoid hemorrhage (Part 1)--With special reference to the relation between cerebral vasospasm and fibrinopeptides A and B beta].
    Touho H; Hino A; Suzuki K; Kubo T; Hirakawa K
    No To Shinkei; 1984 Oct; 36(10):1009-14. PubMed ID: 6518124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of abnormal fibrinogens--introduction of new strategies].
    Matsuda M; Yoshida N; Terukina S; Yamazumi K; Asakura S; Maekawa H
    Rinsho Byori; 1989 Apr; Spec No 81():55-63. PubMed ID: 2754812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.